OS by histology (squamous and nonsquamous) and tumor PD-L1 expression (< 1% and ≥ 1%) also favored nivolumab plus ipilimumab combined with chemotherapy compared with chemotherapy (Online Resource 1). Here, CD274 is linked to neoplasm.